tgrx-678
Small moleculeexperimental
Clinical trial activity
5 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Mar 29, 2021 (NCT05434312)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06986772 | Phase 1 | Jul 7, 2025 | Government of China, Soochow University |
| NCT06697899 | Phase 1 | Nov 20, 2024 | Government of China, Nanjing Medical University, Nanjing University |
| NCT06453902 | Phase 2 | Jun 15, 2024 | Government of China, Peking University |
| NCT06088888 | Phase 1 | Nov 30, 2023 | Government of China, University of Texas at Houston |
| NCT05434312 | Phase 1 | Mar 29, 2021 | Government of China, Peking University |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Government of China | Government | 5 | 5 | 2 | 2021 |
| Peking University | Academic/Hospital | 2 | 0 | 2 | 2021 |
| Nanjing Medical University | Academic/Hospital | 1 | 0 | 1 | 2024 |
| Nanjing University | Academic/Hospital | 1 | 0 | 1 | 2024 |
| Soochow University | Academic/Hospital | 1 | 0 | 1 | 2025 |
| University of Texas at Houston | Academic/Hospital | 1 | 0 | 1 | 2023 |
6 organizations
Page 1 / 1